Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Kestra Medical Technologies, Ltd. (KMTS : NSDQ)

• Company Description    Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. Kestra Medical Technologies, Ltd. is based in KIRKLAND, Wash. Number of Employees: 330

• Price / Volume Information    Yesterday's Closing Price: $21.83 Daily Weekly Monthly 20 Day Moving Average: 227,238 shares Shares Outstanding: 51.35 (millions) Market Capitalization: $1,120.95 (millions) Beta: 52 Week High: $26.15 52 Week Low: $13.25 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 36.78% 34.38% 12 Week 40.79% 27.89% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3933 Lake Washington Blvd NE Suite 200 - Kirkland,WA 98033 USA ph: 425-279-8002 fax: - investor.relations@kestramedical.com http://www.kestramedical.com

• General Corporate Information    Officers Brian Webster - President and Chief Executive Officer Jeff Schwartz - Chairman Vaseem Mahboob - Chief Financial Officer Traci Umberger - General Counsel; Chief Administrative Officer and Christopher Gordon - Director Peer Information Kestra Medical Technologies, Ltd. (BJCT) Kestra Medical Technologies, Ltd. (CADMQ) Kestra Medical Technologies, Ltd. (APNO) Kestra Medical Technologies, Ltd. (UPDC) Kestra Medical Technologies, Ltd. (IMTIQ) Kestra Medical Technologies, Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: G52441105 SIC: 3841 Fiscal Year Fiscal Year End: April Last Reported Quarter: 07/01/25 Next Expected EPS Date: 09/11/25 Share - Related Items Shares Outstanding: 51.35 Most Recent Split Date: (:1) Beta: Market Capitalization: $1,120.95 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.65 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.61 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 18.45% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.46 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 77.99% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 12.41% ROE 07/31/25 - - 04/30/25 - - 01/31/25 - - ROA 07/31/25 - - 04/30/25 - - 01/31/25 - - Current Ratio 07/31/25 - - 04/30/25 - 6.72 01/31/25 - - Quick Ratio 07/31/25 - - 04/30/25 - 6.72 01/31/25 - - Operating Margin 07/31/25 - - 04/30/25 - - 01/31/25 - - Net Margin 07/31/25 - - 04/30/25 - - 01/31/25 - - Pre-Tax Margin 07/31/25 - - 04/30/25 - -190.05 01/31/25 - - Book Value 07/31/25 - - 04/30/25 - 4.00 01/31/25 - - Inventory Turnover 07/31/25 - - 04/30/25 - - 01/31/25 - - Debt-to-Equity 07/31/25 - - 04/30/25 - 0.20 01/31/25 - - Debt-to-Capital 07/31/25 - - 04/30/25 - 16.67 01/31/25 - -

Powered by Zacks Investment Research ©